DEFENDER
@defender-project.bsky.social
Preparing for the future with innovative antiviral solutions.
Last week, our symposium wrapped up with a DEFENDER-internal program on day 2 at the @leibnizliv.bsky.social! 💪
It was fantastic connecting in person with so many brilliant minds — discussing ongoing projects, exploring new collabs, and sharing ideas that move our consortium forward.
#FundedByEU
It was fantastic connecting in person with so many brilliant minds — discussing ongoing projects, exploring new collabs, and sharing ideas that move our consortium forward.
#FundedByEU
November 11, 2025 at 7:38 AM
Last week, our symposium wrapped up with a DEFENDER-internal program on day 2 at the @leibnizliv.bsky.social! 💪
It was fantastic connecting in person with so many brilliant minds — discussing ongoing projects, exploring new collabs, and sharing ideas that move our consortium forward.
#FundedByEU
It was fantastic connecting in person with so many brilliant minds — discussing ongoing projects, exploring new collabs, and sharing ideas that move our consortium forward.
#FundedByEU
What an incredible experience at DEFENDER 2025: International Symposium — huge thanks to all participants for the inspiring discussions and great energy! 💡
We loved exchanging ideas on emerging viruses, new methods & cutting-edge research.
We loved exchanging ideas on emerging viruses, new methods & cutting-edge research.
November 11, 2025 at 7:30 AM
What an incredible experience at DEFENDER 2025: International Symposium — huge thanks to all participants for the inspiring discussions and great energy! 💡
We loved exchanging ideas on emerging viruses, new methods & cutting-edge research.
We loved exchanging ideas on emerging viruses, new methods & cutting-edge research.
Today’s the day! 🎉
We’re looking forward to the DEFENDER 2025: International Symposium in Hamburg, bringing together experts to foster international scientific exchange, strategic project planning, and interdisciplinary networking across virology, immunology, and related fields.
We’re looking forward to the DEFENDER 2025: International Symposium in Hamburg, bringing together experts to foster international scientific exchange, strategic project planning, and interdisciplinary networking across virology, immunology, and related fields.
November 6, 2025 at 7:30 AM
Today’s the day! 🎉
We’re looking forward to the DEFENDER 2025: International Symposium in Hamburg, bringing together experts to foster international scientific exchange, strategic project planning, and interdisciplinary networking across virology, immunology, and related fields.
We’re looking forward to the DEFENDER 2025: International Symposium in Hamburg, bringing together experts to foster international scientific exchange, strategic project planning, and interdisciplinary networking across virology, immunology, and related fields.
Reposted by DEFENDER
🌍 Join us at the @defender-project.bsky.social International Symposium for a keynote by our #combineMARV coordinator @christian-7.bsky.social!
🎟️ Register free of charge for a day of insights, collaboration & global exchange 🔗 lnkd.in/eY9JwzXY
#PandemicPreparedness #Collaboration #EUfunded
🎟️ Register free of charge for a day of insights, collaboration & global exchange 🔗 lnkd.in/eY9JwzXY
#PandemicPreparedness #Collaboration #EUfunded
October 28, 2025 at 12:22 PM
🌍 Join us at the @defender-project.bsky.social International Symposium for a keynote by our #combineMARV coordinator @christian-7.bsky.social!
🎟️ Register free of charge for a day of insights, collaboration & global exchange 🔗 lnkd.in/eY9JwzXY
#PandemicPreparedness #Collaboration #EUfunded
🎟️ Register free of charge for a day of insights, collaboration & global exchange 🔗 lnkd.in/eY9JwzXY
#PandemicPreparedness #Collaboration #EUfunded
👏 Featuring @alexkupke.bsky.social at the Philipp University of Marburg.
We’re excited to highlight Alex Kupke, a DEFENDER partner based at the Institute of Virology at Philipp University of Marburg. Her research plays a vital role in advancing our understanding of high-consequence viral threats.
We’re excited to highlight Alex Kupke, a DEFENDER partner based at the Institute of Virology at Philipp University of Marburg. Her research plays a vital role in advancing our understanding of high-consequence viral threats.
June 18, 2025 at 6:35 AM
👏 Featuring @alexkupke.bsky.social at the Philipp University of Marburg.
We’re excited to highlight Alex Kupke, a DEFENDER partner based at the Institute of Virology at Philipp University of Marburg. Her research plays a vital role in advancing our understanding of high-consequence viral threats.
We’re excited to highlight Alex Kupke, a DEFENDER partner based at the Institute of Virology at Philipp University of Marburg. Her research plays a vital role in advancing our understanding of high-consequence viral threats.
🚀 Introducing Andrea Maisner
Andrea is a renowned virologist whose research is at the forefront of understanding Nipah virus — a highly pathogenic zoonotic paramyxovirus with no approved vaccines or treatments.
Andrea is a renowned virologist whose research is at the forefront of understanding Nipah virus — a highly pathogenic zoonotic paramyxovirus with no approved vaccines or treatments.
June 11, 2025 at 11:01 AM
🚀 Introducing Andrea Maisner
Andrea is a renowned virologist whose research is at the forefront of understanding Nipah virus — a highly pathogenic zoonotic paramyxovirus with no approved vaccines or treatments.
Andrea is a renowned virologist whose research is at the forefront of understanding Nipah virus — a highly pathogenic zoonotic paramyxovirus with no approved vaccines or treatments.
🚀 Meet @lisa-oestereich.bsky.social
Lisa is a leading virologist based at the BNITM in Hamburg, Germany. Her research focuses on some of the world’s most dangerous viruses — including Lassa, Ebola, and Crimean-Congo hemorrhagic fever viruses.
Lisa is a leading virologist based at the BNITM in Hamburg, Germany. Her research focuses on some of the world’s most dangerous viruses — including Lassa, Ebola, and Crimean-Congo hemorrhagic fever viruses.
June 4, 2025 at 10:42 AM
🚀 Meet @lisa-oestereich.bsky.social
Lisa is a leading virologist based at the BNITM in Hamburg, Germany. Her research focuses on some of the world’s most dangerous viruses — including Lassa, Ebola, and Crimean-Congo hemorrhagic fever viruses.
Lisa is a leading virologist based at the BNITM in Hamburg, Germany. Her research focuses on some of the world’s most dangerous viruses — including Lassa, Ebola, and Crimean-Congo hemorrhagic fever viruses.
Reposted by DEFENDER
Wie vermehren sich neu auftretende Viren wie das Coronavirus – und steckt darin der Schlüssel für neue Therapien? Prof. Stephanie Pfänder gibt im Video Einblicke in die Arbeit ihrer LIV-Forschungsgruppe "Emerging Viruses".
youtu.be/eKZr3nhqeB0?...
@pfaenderlab.bsky.social
@leibniz-gemeinschaft.de
youtu.be/eKZr3nhqeB0?...
@pfaenderlab.bsky.social
@leibniz-gemeinschaft.de
Forschungsgruppe Emerging Viruses (Prof. Dr. Stephanie Pfänder)
YouTube video by Leibniz-Institut für Virologie (LIV)
youtu.be
May 5, 2025 at 3:44 PM
Wie vermehren sich neu auftretende Viren wie das Coronavirus – und steckt darin der Schlüssel für neue Therapien? Prof. Stephanie Pfänder gibt im Video Einblicke in die Arbeit ihrer LIV-Forschungsgruppe "Emerging Viruses".
youtu.be/eKZr3nhqeB0?...
@pfaenderlab.bsky.social
@leibniz-gemeinschaft.de
youtu.be/eKZr3nhqeB0?...
@pfaenderlab.bsky.social
@leibniz-gemeinschaft.de
We’re excited to introduce Mark Broenstrup, Head of the Department of Chemical Biology at the @helmholtzhzi.bsky.social (HZI), as a PI in the DEFENDER project.
His team brings cutting-edge expertise in the design and optimization of bioactive compounds for therapeutic use.
His team brings cutting-edge expertise in the design and optimization of bioactive compounds for therapeutic use.
May 5, 2025 at 7:54 AM
We’re excited to introduce Mark Broenstrup, Head of the Department of Chemical Biology at the @helmholtzhzi.bsky.social (HZI), as a PI in the DEFENDER project.
His team brings cutting-edge expertise in the design and optimization of bioactive compounds for therapeutic use.
His team brings cutting-edge expertise in the design and optimization of bioactive compounds for therapeutic use.
Introducing @chlandalab.bsky.social – an expert at the frontier of structural virology!
Petr leads a research group dedicated to understanding how viruses interact with cellular organelles and manipulate host cells for replication.
Petr leads a research group dedicated to understanding how viruses interact with cellular organelles and manipulate host cells for replication.
April 30, 2025 at 12:37 PM
Introducing @chlandalab.bsky.social – an expert at the frontier of structural virology!
Petr leads a research group dedicated to understanding how viruses interact with cellular organelles and manipulate host cells for replication.
Petr leads a research group dedicated to understanding how viruses interact with cellular organelles and manipulate host cells for replication.
🚀 Introducing Bruno Correia
Bruno leads a cutting-edge research group at EPFL focused on developing computational tools for protein design, with a strong emphasis on immunoengineering applications like vaccines and cancer immunotherapy.
Bruno leads a cutting-edge research group at EPFL focused on developing computational tools for protein design, with a strong emphasis on immunoengineering applications like vaccines and cancer immunotherapy.
April 25, 2025 at 1:20 PM
🚀 Introducing Bruno Correia
Bruno leads a cutting-edge research group at EPFL focused on developing computational tools for protein design, with a strong emphasis on immunoengineering applications like vaccines and cancer immunotherapy.
Bruno leads a cutting-edge research group at EPFL focused on developing computational tools for protein design, with a strong emphasis on immunoengineering applications like vaccines and cancer immunotherapy.
Spotlight on Lars Kaderali
We’re proud to shine a light on Prof. Dr. Lars Kaderali, a driving force behind the integration of artificial intelligence in biomedical research.
We’re proud to shine a light on Prof. Dr. Lars Kaderali, a driving force behind the integration of artificial intelligence in biomedical research.
April 16, 2025 at 6:01 AM
Spotlight on Lars Kaderali
We’re proud to shine a light on Prof. Dr. Lars Kaderali, a driving force behind the integration of artificial intelligence in biomedical research.
We’re proud to shine a light on Prof. Dr. Lars Kaderali, a driving force behind the integration of artificial intelligence in biomedical research.
We're excited to share a recent SWR NANO feature highlighting DEFENDER that takes us behind the scenes of the impressive work done by the @chlandalab.bsky.social Lab at @uniheidelberg.bsky.social! 🧬 The feature starts at minute 18:58 – be sure to tune in!
👉 www.3sat.de/wissen/nano/...
👉 www.3sat.de/wissen/nano/...
April 10, 2025 at 8:02 AM
We're excited to share a recent SWR NANO feature highlighting DEFENDER that takes us behind the scenes of the impressive work done by the @chlandalab.bsky.social Lab at @uniheidelberg.bsky.social! 🧬 The feature starts at minute 18:58 – be sure to tune in!
👉 www.3sat.de/wissen/nano/...
👉 www.3sat.de/wissen/nano/...
Spotlight on Marie Flamand
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
April 10, 2025 at 6:51 AM
Spotlight on Marie Flamand
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
Eike Steinmann heads the Department of Molecular & Medical Virology at @ruhr-uni-bochum.de 🧬. His team is at the forefront of groundbreaking research, exploring RNA virus replication mechanisms and transmission routes, with a focus on flavi- and coronaviruses.
April 4, 2025 at 8:42 AM
Eike Steinmann heads the Department of Molecular & Medical Virology at @ruhr-uni-bochum.de 🧬. His team is at the forefront of groundbreaking research, exploring RNA virus replication mechanisms and transmission routes, with a focus on flavi- and coronaviruses.
👉 Introducing Thomas Strecker
We’re excited to introduce Thomas, a @defender-project.bsky.social partner working at the @unimarburg.bsky.social! Thomas and his research group focus on unraveling the infection mechanisms of Lassa virus (LASV) – a major public health threat in West Africa 🌍 .
We’re excited to introduce Thomas, a @defender-project.bsky.social partner working at the @unimarburg.bsky.social! Thomas and his research group focus on unraveling the infection mechanisms of Lassa virus (LASV) – a major public health threat in West Africa 🌍 .
March 28, 2025 at 7:17 AM
👉 Introducing Thomas Strecker
We’re excited to introduce Thomas, a @defender-project.bsky.social partner working at the @unimarburg.bsky.social! Thomas and his research group focus on unraveling the infection mechanisms of Lassa virus (LASV) – a major public health threat in West Africa 🌍 .
We’re excited to introduce Thomas, a @defender-project.bsky.social partner working at the @unimarburg.bsky.social! Thomas and his research group focus on unraveling the infection mechanisms of Lassa virus (LASV) – a major public health threat in West Africa 🌍 .
Featuring @goffinetlab.bsky.social at @lstmnews.bsky.social
We're proud to collaborate with leading virologists working to combat emerging viral threats. Christine, a DEFENDER partner at the LSTM, is making significant strides in studying alphaviruses, including chikungunya and Mayaro viruses.
We're proud to collaborate with leading virologists working to combat emerging viral threats. Christine, a DEFENDER partner at the LSTM, is making significant strides in studying alphaviruses, including chikungunya and Mayaro viruses.
March 25, 2025 at 6:45 AM
Featuring @goffinetlab.bsky.social at @lstmnews.bsky.social
We're proud to collaborate with leading virologists working to combat emerging viral threats. Christine, a DEFENDER partner at the LSTM, is making significant strides in studying alphaviruses, including chikungunya and Mayaro viruses.
We're proud to collaborate with leading virologists working to combat emerging viral threats. Christine, a DEFENDER partner at the LSTM, is making significant strides in studying alphaviruses, including chikungunya and Mayaro viruses.
🚀 Meet Adriano Aguzzi 🧠🔬
Adriano Aguzzi, PI at UZH, has dedicated his career to unraveling the relationship between the immune system and prion diseases. His cutting-edge research employs high-throughput CRISPR screens to pinpoint key factors in prion replication and infection susceptibility.
Adriano Aguzzi, PI at UZH, has dedicated his career to unraveling the relationship between the immune system and prion diseases. His cutting-edge research employs high-throughput CRISPR screens to pinpoint key factors in prion replication and infection susceptibility.
March 21, 2025 at 7:05 AM
🚀 Meet Adriano Aguzzi 🧠🔬
Adriano Aguzzi, PI at UZH, has dedicated his career to unraveling the relationship between the immune system and prion diseases. His cutting-edge research employs high-throughput CRISPR screens to pinpoint key factors in prion replication and infection susceptibility.
Adriano Aguzzi, PI at UZH, has dedicated his career to unraveling the relationship between the immune system and prion diseases. His cutting-edge research employs high-throughput CRISPR screens to pinpoint key factors in prion replication and infection susceptibility.
✨ Spotlight on @kreylab.bsky.social ! ✨
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
March 18, 2025 at 8:21 PM
✨ Spotlight on @kreylab.bsky.social ! ✨
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
🌟 Meet our first PI and project coordinator: @pfaenderlab.bsky.social! 🌟
March 17, 2025 at 9:00 AM
🌟 Meet our first PI and project coordinator: @pfaenderlab.bsky.social! 🌟
The DEFENDER project has officially launched!
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org
DEFENDER
defender-project.org
March 13, 2025 at 10:56 AM
The DEFENDER project has officially launched!
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org